Sage Rhino Capital »

Arrowhead Pharmaceuticals shares owned by Sage Rhino Capital

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Sage Rhino Capital from 13F filings

Historical chart of Sage Rhino Capital investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Sage Rhino Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Sage Rhino Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $348k 5.2k 66.39

More positions owned by Sage Rhino Capital

Ishares Gold Tr Ishares New (IAU)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core Msci Eafe (IEFA)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Apple (AAPL)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SDY)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
American Centy Etf Tr Intl Eqt Etf (AVDE)

View all positions for Sage Rhino Capital

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals